NEW YORK (360Dx) – A*STAR and its spinoff One BioMed said today that they recently launched a Singapore $9 million (US$6.6 million) lab with an aim to commercialize a point-of-care diagnostic kit within the next five years that can concurrently test for up to 20 types of infectious diseases in 20 minutes.